相关实验视频

Updated: May 12, 2025

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

抑制PAD4会影响SARS-CoV-2感染时的免疫反应

Caio Santos Bonilha¹, Flavio Protasio Veras², Anderson Dos Santos Ramos³

¹Center for Research in Inflammatory Diseases, Ribeirao Preto Medical School, University of Sao Paulo, 14049-900, Brazil; Institute of Infection, Immunity and Inflammation, University of Glasgow, G12 8TA, UK; Institute of Developmental & Regenerative Medicine, University of Oxford, OX3 7TY, UK.

Mucosal immunology

|April 21, 2025

概括

向蛋白质氨酸减小酶4 (PAD4) 减少COVID-19中的肺 NET,但可能会损害关键的T细胞反应. 需要对PAD4作为治疗点进行仔细评估.

科学领域:

免疫学免疫学免疫学
分子生物学分子生物学
病理学病理学病理学

背景情况:

中性细胞外细胞陷 (NETs) 在SARS-CoV-2感染期间与肺损伤有关.
蛋白质氨酸减小酶4 (PAD4) 促进了NET的形成,是潜在的治疗点.

研究的目的:

研究PAD4抑制对SARS-CoV-2感染的临床结果和适应性免疫的影响.
为了比较PAD4抑制与复合人类DNase (rhDNase) 治疗.

主要方法:

药理上抑制PAD4.4的作用.
评估肺中的NET度.
对临床结果的评估.
对病毒特异性T细胞反应和树突细胞抗原呈现的分析.
测量T细胞中的IL-2信号.

主要成果:

抑制PAD4减少了肺 NETs,改善了临床结果,类似于rhDNase.
与rhDNase不同的是,PAD4抑制损害了特定于病毒的T细胞反应.
抑制PAD4降低了树突细胞抗原呈现,并减少了T细胞IL-2的产生.
在肺炎模型中,抗原特异性T细胞反应因PAD4抑制而减少.

结论:

虽然PAD4抑制在减少NET和改善COVID-19的结果方面表现有希望,但它可能会损害必要的适应性免疫反应.
进一步的研究至关重要,以权衡使用PAD4抑制剂治疗COVID-19等病毒感染的益处与风险.

关键词:

抗原呈现方式在 COVID-19 疫情中,树突性细胞树突性细胞细胞外的陷细胞外的陷

更多相关视频

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

相关概念视频

Factors Affecting the Risk of Infection

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...